Atox Bio's Series C Round

Atox Bio raised a round of funding on October 14, 2010.

Atox Bio is a clinical stage biotechnology company that develops therapeutics for diseases mediated by a deregulated inflammatory response. Atox Bio focuses on novel modulators of the immune response …

Articles about Atox Bio's Series C Round: